Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01271491 · ClinicalTrials.gov registry record

The Genetics of Respiratory Failure in Bronchiolitis

A clinical trial, sponsored by Connecticut Children's Medical Center.

Completed
Registry status
174
Enrollment target

NCT01271491 is a clinical trial that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 174 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01271491 has completed, sponsored by Connecticut Children's Medical Center.

COMPLETED
Registry status
174 participants
Enrollment target

Study Summary

Bronchiolitis is a potentially severe infection of the airway in infants and children, and among the most frequent diagnoses leading to pediatric intensive care unit admission in infants. This acute infection is caused by an array of viruses, but respiratory syncytial virus (RSV) is the most frequently implicated. The majority of infants hospitalized with bronchiolitis are previously healthy, and half of infants intubated and mechanically ventilated for respiratory failure due to RSV bronchiolitis have no previously identified risk factors. It is likely, therefore, that other factors, particularly genetic heterogeneity of the host, contribute to disease severity. However, no previous study has investigated the association of genetic variants with respiratory failure in children with bronchiolitis. Several categories of candidate genes have emerged as potentially important in the pathogenesis of the disease. Specifically, genetic polymorphisms of surfactants, pattern recognition receptors, receptor adhesion molecules, and cytokines have been examined. The aim is to evaluate these polymorphisms to determine their association with respiratory failure in a cohort of more severely ill children with bronchiolitis.

Trial Details

FieldValue
Enrollment Target 174 participants
Start Date 2010-11
Est. Completion 2018-10

What the Registry Record Tells You About NCT01271491

The ClinicalTrials.gov registry entry for NCT01271491 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01271491 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01271491 about?

NCT01271491 is a clinical study titled "The Genetics of Respiratory Failure in Bronchiolitis". Bronchiolitis is a potentially severe infection of the airway in infants and children, and among the most frequent diagnoses leading to pediatric intensive care unit admission in infants. This acute infection is caused by an array of viruses, but respiratory syncytial virus (RSV) is the most frequen...

What is the current status of trial NCT01271491?

This trial is currently completed. The enrollment target is 174 participants. The study started on 2010-11. Estimated completion is 2018-10.

Who is sponsoring clinical trial NCT01271491?

This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.